These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 804400)

  • 1. Central nervous system effects of hypothalamic peptides.
    Brown M; Vale W
    Endocrinology; 1975 May; 96(5):1333-6. PubMed ID: 804400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intraventricular administration of anti-somatostatin gamma-globulin on the lethal dose-50 of strychnine and pentobarbital in rats.
    Chihara K; Arimura A; Chihara M; Schally AV
    Endocrinology; 1978 Sep; 103(3):912-6. PubMed ID: 84754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone release in the rat: effects of somatostatin and thyrotropin-releasing factor.
    Brown M; Vale W
    Endocrinology; 1975 Nov; 97(5):1151-6. PubMed ID: 810343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-related toxicity of somatostatin and its interaction with pentobarbital and strychnine.
    Caprino L; Borrelli F; Antonetti F; Cantelmo A
    Toxicol Lett; 1983 Jun; 17(1-2):145-9. PubMed ID: 6137886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theanine enhanced both the toxicity of strychnine and anticonvulsion of pentobarbital sodium.
    Yu XC; Wu BL; Gao JC; Yang W
    Drug Chem Toxicol; 2016; 39(2):217-23. PubMed ID: 26330182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine influences on the actions of morphine. III. Responses to hypothalamic hormones.
    Kasson BG; George R
    Neuroendocrinology; 1983 Dec; 37(6):416-20. PubMed ID: 6140650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of hypothalamic-hypophysiotropic hormones on the brain.
    Moss RL
    Annu Rev Physiol; 1979; 41():617-31. PubMed ID: 219767
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biological action of synthetic hypothalamic hormone TRF (thyrortropin-releasing factor). 2. Specificity and modifying factor of synthetic of biological action of TRF].
    Sakoda M; Otsuki M; Kusaka T; Mori H; Mineyama T
    Nihon Naibunpi Gakkai Zasshi; 1970 Oct; 46(7):826-9. PubMed ID: 4991361
    [No Abstract]   [Full Text] [Related]  

  • 9. Central nervous system drugs and x-irradiation: their interactive effects.
    Barnes CD
    Radiat Res; 1967 Feb; 30(2):351-8. PubMed ID: 6019786
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral administration of hypothalamic peptides results in CNS changes.
    Kastin AJ; Coy DH; Schally AV; Miller LH
    Pharmacol Res Commun; 1978 Apr; 10(4):293-312. PubMed ID: 28532
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative evaluation of the antitoxic activity of central nervous system analeptics and their combinations in barbamyl poisoning].
    Stanishevskaia AV; Kudrin AN
    Farmakol Toksikol; 1975; 38(2):152-4. PubMed ID: 6301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity of animals to central nervous system stimulants in hypokinesia].
    Kolemeeva LIa; Shashkov VS; Egorov BB
    Kosm Biol Aviakosm Med; 1977; 11(2):74-9. PubMed ID: 15162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotensin: central nervous system effects of a hypothalamic peptide.
    Nemeroff CB; Bissette G; Prange AJ; Loosen PT; Barlow TS; Lipton MA
    Brain Res; 1977 Jun; 128(3):485-96. PubMed ID: 406965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic peptides: central nervous system control of visceral functions.
    Brown M; Taché Y
    Fed Proc; 1981 Sep; 40(11):2565-9. PubMed ID: 6115772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin-releasing factor-induced adrenocorticotropin secretion is mediated by corticotropin-releasing factor.
    Brown MR; Carver-Moore K; Gray TS; Rivier C
    Endocrinology; 1989 Nov; 125(5):2558-62. PubMed ID: 2551657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptides: central nervous system effects on nutrient metabolism.
    Brown M
    Diabetologia; 1981 Mar; 20 Suppl():299-304. PubMed ID: 6112188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
    Michalkiewicz M; Suzuki M; Kato M
    Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameters of alteration of pentobarbital response by hypothalamic polypeptides.
    Prange AJ; Breese GR; Jahnke GD; Cooper BR; Cott JM; Wilson IC; Lipton MA; Plotnikoff NP
    Neuropsychobiology; 1975; 1(2):121-31. PubMed ID: 817220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS depressant activity of Lecaniodiscus cupanioides.
    Yemitan OK; Adeyemi OO
    Fitoterapia; 2005 Jul; 76(5):412-8. PubMed ID: 15955638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.